NVO241115P109000
- 6.90
- +2.95+74.68%
Novo-Nordisk A/S Newsroom
Express News | The weight loss version of semaglutide has officially launched in china.
Express News | Novo Nordisk's GLP-1 weight loss drug officially enters China, how is it priced?
Duan Yongping and Buffett have a "soul resonance" in their third-quarter operations, and Li Lu re-enters an oil & gas stock.
For nvidia, Bridgewater, Jinglin, Baillie Gifford, and "Cathie Wood" are all reducing their shareholding, and everyone is quietly united in missing the opportunity of nvidia reaching the top of the market cap.
The "most lethal in history" nomination of the usa Secretary of Health! Vaccine stocks have been plummeting for consecutive days, and Kennedy has been criticized as the number one threat to public health.
On Friday, biontech once fell nearly 9%, moderna fell over 7%, and nasdaq biotechnology index dropped over 4%. Industry insiders said that Kennedy's 'junk science' poses a huge threat to public health.
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Shares of Pharmaceutical Companies Are Trading Lower After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.
RFK Jr. Is Not a Fan of Weight-loss Drugs or Vaccines. Stocks Are Tanking.
Express News | Biotechnology etf plunges! Pharmaceutical stocks collectively decline, with the United States Secretary of Health and Human Services nominee raising market concerns.
This Is What Whales Are Betting On Novo Nordisk
Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter
Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ
Top private equity funds in China expose the 'US stock report': the proportion of Chinese concept stocks continues to rise, with PDD Holdings and Apple being the focus of differences in components.
In the third quarter of this year, most Chinese private equity firms, such as Hillhouse, Gao Yi, and Jinglin, remained focused on Chinese concept stocks. However, Hillhouse and Jinglin chose to reduce their shareholding in pdd holdings, while Gao Yi opted to continue increasing its stake in pdd holdings.
Is the weight loss drug market huge? The Lancet predicts that the overweight population in the usa will increase significantly.
Research warnings indicate that the obesity crisis in the usa is expected to worsen by 2050.
Coatue Management Top Q3 Moves: Cuts Nvidia, Exits CRM & UNH, Piles Into Chinese Stocks
Novo Nordisk to Phase Out Human Insulin Pens: Report
Global Increase in Diabetes Indicates More Room for GLP-1 Meds to Grow
Eli Lilly and Co. is startled, novo-nordisk a/s saves the day! The market prospects for weight loss drugs still tempt many players.
The weight loss drug market still has a broad prospect, with most institutions predicting that the market size will reach the trillion-dollar level by the end of this decade.
EU regulatory institutions are inquiring about Novo Nordisk's acquisition of catalent.
According to sources, on November 14, the European Union's antitrust regulatory agency has requested feedback from pharmaceutical industry competitors and customers on four business areas regarding Novo Holdings' plan to invest $16.5 billion in acquiring Catalent. Novo Holdings, the controlling shareholder of Danish pharmaceutical company Novo Nordisk A/S, has become the highest market cap company in Europe driven by the generous profits from the popular weight loss drug Wegovy. While survey results show that the European Commission is seeking market insights, it may allow competitors and customers to raise potential antitrust concerns.
Unusual Options Activity: NVO, CSCO and Others Attract Market Bets, NVO V/OI Ratio Reaches 754.9
EST Nov 13th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options